Boom times for the regulatory affairs profession

It's a good time to be in regulatory affairs. Analysts at Cutting Edge Information say that rising salaries in the field have pushed up the budgets at the top 50 pharma companies by 27% since 2010. And the bigger companies are raiding the smaller ones in the hunt for fresh talent. "The simple reason is that regulatory affairs professionals are in high demand right now, especially among large pharmaceutical companies," says Ryan McGuire. Release

Suggested Articles

Solid Bio fixed the manufacturing issue that led to a partial clinical hold on its DMD trial, but a full hold remains.

Commissioner Scott Gottlieb has laid out the reasons why he thinks the FDA needs a double-digit budget bump.

GW's cannabis-based epilepsy drug scored a favorable review from FDA staff ahead of an expert panel meeting.